Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity RatioInvested CapitalReturn on AssetsReturn on Capital Employed

Cardiol Therapeutics (CRDL) Return on Capital Employed (2021 - 2026)

Cardiol Therapeutics filings provide 1 years of Return on Capital Employed readings, the most recent being 76.03% for Q4 2022.

  • On a quarterly basis, Return on Capital Employed changed N/A to 76.03% in Q4 2022 year-over-year; TTM through Dec 2022 was 76.03%, a N/A change, with the full-year FY2022 number at 60.32%, up 3620.0% from a year prior.
  • Return on Capital Employed hit 76.03% in Q4 2022 for Cardiol Therapeutics, down from 69.22% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 48.33% in Q1 2022 to a low of 76.03% in Q4 2022.